GSK shares fell after a Food and Drug Administration advisory committee voted against approval of the company's Blenrep drug, a setback for its bid to reintroduce the blood-cancer treatment in the U.S ...

Arbitrators cleared the way for the long-delayed $53 billion acquisition after Exxon tried to pre-empt the deal. 3M raised its full-year earnings outlook after beating expectations in the second ...

GSK PLC closed 19.70% below its 52-week high of £16.79, which the company achieved on September 9th.

AnaptysBio’s lead drug rosnilimab showed promise in RA, but lack of a Phase 3 plan and limited pipeline raise concerns. Find ...

Warren Buffett is one of the most renowned investors of our time. So, it’s easy to forget that he was once a beginner too.

Many people think that Warren Buffet is a good lead indicator for financial markets, and Berkshire Hathaway has been offloading US banks in recent months. Many people may ask why sell stocks when they ...

The Swedish defense company posted better-than-expected earnings and [raised its annual sales guidance]( ...

Arexvy is currently approved for use in all individuals aged 60 and older, as well as for high-risk individuals aged 50-59.

Investor sentiment in the restaurant sector is currently strongest for YUM! Brands and Shake Shack (NYSE: SHAK), according to ...